Skip to main content

Advertisement

Log in

Ethical Issues Raised by Proposals to Treat Addiction Using Deep Brain Stimulation

  • Original Paper
  • Published:
Neuroethics Aims and scope Submit manuscript

Abstract

Deep brain stimulation (DBS) has been proposed as a potential treatment of drug addiction on the basis of its effects on drug self-administration in animals and on addictive behaviours in some humans treated with DBS for other psychiatric or neurological conditions. DBS is seen as a more reversible intervention than ablative neurosurgery but it is nonetheless a treatment that carries significant risks. A review of preclinical and clinical evidence for the use of DBS to treat addiction suggests that more animal research is required to establish the safety and efficacy of the technology and to identify optimal treatment parameters before investigating its use in addicted persons. Severely addicted persons who try and fail to achieve abstinence may, however, be desperate enough to undergo such an invasive treatment if they believe that it will cure their addiction. History shows that the desperation for a “cure” of addiction can lead to the use of risky medical procedures before they have been rigorously tested. In the event that DBS is used in the treatment of addiction, we provide minimum ethical requirements for clinical trials of its use in the treatment of addiction. These include: restrictions of trials to severely intractable cases of addiction; independent oversight to ensure that patients have the capacity to consent and give that consent on the basis of a realistic appreciation of the potential benefits and risks of DBS; and rigorous assessments of the effectiveness and safety of this treatment compared to the best available treatments for addiction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Diefenbach, G.J., D. Diefenbach, A. Baumeister, and M. West. 1999. Portrayal of lobotomy in the popular press: 1935–1960. Journal of the History of the Neurosciences 8: 60–69.

    Article  Google Scholar 

  2. Racine, E., O. Bar-Ilan, and J. Illes. 2006. Brain imaging: A decade of coverage in the print media. Science Communication 28: 122–142.

    Article  Google Scholar 

  3. Racine, E., H.Z. van der Loos, and J. Illes. 2007. Internet marketing of neuroproducts: New practices and healthcare policy challenges. Cambridge Quarterly of Healthcare Ethics 16: 181–194.

    Google Scholar 

  4. Hall, W. 2000. UROD: An antipodean therapeutic enthusiasm. Addiction 95: 1765–1766.

    Article  Google Scholar 

  5. Hall, W. 2006. Stereotactic neurosurgical treatment of addiction: Minimising the chances of another ‘great and desperate cure’. Addiction 101: 1–3.

    Google Scholar 

  6. Talan, J. 2009. Deep brain stimulation: A new treatment shows promise in the most difficult cases. New York/Washington DC: Dana.

    Google Scholar 

  7. Bauer, R., S. Pohl, J. Klosterkotter, and J. Kuhn. 2008. Deep brain stimulation in the context of addiction—a literature-based systematic evaluation. Fortschritte der Neurologie-Psychiatrie 76: 396–401.

    Article  Google Scholar 

  8. Stelten, B.M., L.H. Noblesse, L. Ackermans, Y. Temel, and V. Visser-Vandewalle. 2008. The neurosurgical treatment of addiction. Neurosurgical Focus 25: E5.

    Article  Google Scholar 

  9. Lu, L., X. Wang, and T.R. Kosten. 2009. Stereotactic neurosurgical treatment of drug addiction. American Journal of Drug and Alcohol Abuse 35: 391–393.

    Article  Google Scholar 

  10. Yamada, K., T. Hamasaki, and J. Kuratsu. 2009. Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson’s disease—retrospective evaluation of postoperative independence in pursuing daily activities. Parkinsonism and Related Disorders 15: 746–751.

    Article  Google Scholar 

  11. Schupbach, W.M., D. Maltete, J.L. Houeto, S.T. du Montcel, L. Mallet, M.L. Welter, M. Gargiulo, C. Behar, A.M. Bonnet, V. Czernecki, B. Pidoux, S. Navarro, D. Dormont, P. Cornu, and Y. Agid. 2007. Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial. Neurology 68: 267–271.

    Article  Google Scholar 

  12. Food and Drug Administration. 2009. FDA approves humanitarian device exemption for deep brain stimulator for severe obsessive-compulsive disorder. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149529.htm. Accessed 31 August 2009.

  13. Servello, D., M. Porta, M. Sassi, A. Brambilla, and M.M. Robertson. 2008. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: The surgery and stimulation. Journal of Neurology, Neurosurgery and Psychiatry 79: 136–142.

    Article  Google Scholar 

  14. Visser-Vandewalle, V., L. Ackermans, C. van der Linden, Y. Temel, M.A. Tijssen, K.R. Schruers, P. Nederveen, M. Kleijer, P. Boon, W. Weber, and D. Cath. 2006. Deep brain stimulation in Gilles de la Tourette’s syndrome. Neurosurgery 58: E590.

    Google Scholar 

  15. Greenberg, B.D., D.A. Malone, G.M. Friehs, A.R. Rezai, C.S. Kubu, P.F. Malloy, S.P. Salloway, M.S. Okun, W.K. Goodman, and S.A. Rasmussen. 2006. Three-year outcomes in deep brain stimulation for highly resistant obsessive–compulsive disorder. Neuropsychopharmacology 31: 2384–2393.

    Article  Google Scholar 

  16. Lipsman, N., J.S. Neimat, and A.M. Lozano. 2007. Deep brain stimulation for treatment-refractory obsessive–compulsive disorder: The search for a valid target. Neurosurgery 61: 1–11. discussion 11–13.

    Article  Google Scholar 

  17. Mayberg, H.S., A.M. Lozano, V. Voon, H.E. McNeely, D. Seminowicz, C. Hamani, J.M. Schwalb, and S.H. Kennedy. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45: 651–660.

    Article  Google Scholar 

  18. Schlaepfer, T.E., M.X. Cohen, C. Frick, M. Kosel, D. Brodesser, N. Axmacher, A.Y. Joe, M. Kreft, D. Lenartz, and V. Sturm. 2008. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33: 368–377.

    Article  Google Scholar 

  19. Synofzik, M., and T.E. Schlaepfer. 2008. Stimulating personality: Ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Biotechnology Journal 3: 1511–1520.

    Article  Google Scholar 

  20. Hamani, C., M.P. McAndrews, M. Cohn, M. Oh, D. Zumsteg, C.M. Shapiro, R.A. Wennberg, and A.M. Lozano. 2008. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Annals of Neurology 63: 119–123.

    Article  Google Scholar 

  21. Sani, S., K. Jobe, A. Smith, J.H. Kordower, and R.A. Bakay. 2007. Deep brain stimulation for treatment of obesity in rats. Journal of Neurosurgery 107: 809–813.

    Article  Google Scholar 

  22. Franzini, A., C. Marras, P. Ferroli, O. Bugiani, and G. Broggi. 2005. Stimulation of the posterior hypothalamus for medically intractable impulsive and violent behavior. Stereotactic and Functional Neurosurgery 83: 63–66.

    Article  Google Scholar 

  23. Quaade, F. 1974. Stereotaxy for obesity. The Lancet 303: 267–267.

    Article  Google Scholar 

  24. Capel, I.D., inventor Zion Foundation, assignee. 1984. Method and treatment with transcranially applied electrical signals United States Patent and Trademark Office patent 4,646,744. 1984 June 29.

  25. Naqvi, N.H., D. Rudrauf, H. Damasio, and A. Bechara. 2007. Damage to the insula disrupts addiction to cigarette smoking. Science 315: 531–534.

    Article  Google Scholar 

  26. BBC News. 2007 Brain’s ‘addiction centre’ found. BBC News. 25 January: http://news.bbc.co.uk/2/hi/health/6298557.stm. Accessed 2 August 2007.

  27. Robbins, T.W., R.N. Cardinal, P. DiCiano, P.W. Halligan, K.G.G. Hellemans, J.L. Lee, and B.J. Everitt. 2007. Neuroscience of drugs and addiction. In Drugs and the future: Brain science, addiction and society, ed. D. Nutt, T. Robbins, G. Stimson, M. Ince, and A. Jackson, 11–88. London: Academic.

    Google Scholar 

  28. Gao, G., X. Wang, S. He, W. Li, Q. Wang, Q. Liang, Y. Zhao, F. Hou, L. Chen, and A. Li. 2003. Clinical study for alleviating opiate drug psychological dependence by a method of ablating the nucleus accumbens with stereotactic surgery. Stereotactic and Functional Neurosurgery 81: 96–104.

    Article  Google Scholar 

  29. Liu, H.Y., J. Jin, J.S. Tang, W.X. Sun, H. Jia, X.P. Yang, J.M. Cui, and C.G. Wang. 2008. Chronic deep brain stimulation in the rat nucleus accumbens and its effect on morphine reinforcement. Addiction Biology 13: 40–46.

    Article  Google Scholar 

  30. Vassoler, F.M., H.D. Schmidt, M.E. Gerard, K.R. Famous, D.A. Ciraulo, C. Kornetsky, C.M. Knapp, and R.C. Pierce. 2008. Deep brain stimulation of the nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug seeking in rats. Journal of Neuroscience 28: 8735–8739.

    Article  Google Scholar 

  31. Knapp, C.M., L. Tozier, A. Pak, D.A. Ciraulo, and C. Kornetsky. 2009. Deep brain stimulation of the nucleus accumbens reduces ethanol consumption in rats. Pharmacology, Biochemistry & Behavior 92: 474–479.

    Article  Google Scholar 

  32. Rouaud, T., S. Lardeux, N. Panayotis, D. Paleressompoulle, M. Cador, and C. Baunez. 2010. Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation. Proceedings of the National Academy of Sciences 107: 1196–1200.

    Article  Google Scholar 

  33. Baunez, C., C. Dias, M. Cador, and M. Amalric. 2005. The subthalamic nucleus exerts opposite control on cocaine and ‘natural’ rewards. Nature Neuroscience 8: 484–489.

    Google Scholar 

  34. Levy, D., M. Shabat-Simon, U. Shalev, N. Barnea-Ygael, A. Cooper, and A. Zangen. 2007. Repeated electrical stimulation of reward-related brain regions affects cocaine but not “natural” reinforcement. Journal of Neuroscience 27: 14179–14189.

    Article  Google Scholar 

  35. Witjas, T., C. Baunez, J.M. Henry, M. Delfini, J. Regis, A.A. Cherif, J.C. Peragut, and J.P. Azulay. 2005. Addiction in Parkinson’s disease: Impact of subthalamic nucleus deep brain stimulation. Movement Disorders 20: 1052–1055.

    Article  Google Scholar 

  36. Lim, S.Y., S.S. O’Sullivan, K. Kotschet, D.A. Gallagher, C. Lacey, A.D. Lawrence, A.J. Lees, D.J. O’Sullivan, R.F. Peppard, J.P. Rodrigues, A. Schrag, P. Silberstein, S. Tisch, and A.H. Evans. 2009. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson’s disease. Journal of Clinical Neuroscience 16: 1148–1152.

    Article  Google Scholar 

  37. Halbig, T.D., W. Tse, P.G. Frisina, B.R. Baker, E. Hollander, H. Shapiro, M. Tagliati, W.C. Koller, and C.W. Olanow. 2009. Subthalamic deep brain stimulation and impulse control in Parkinson’s disease. European Journal of Neurology 16: 493–497.

    Article  Google Scholar 

  38. Ardouin, C., V. Voon, Y. Worbe, N. Abouazar, V. Czernecki, H. Hosseini, A. Pelissolo, E. Moro, E. Lhommee, A.E. Lang, Y. Agid, A.L. Benabid, P. Pollak, L. Mallet, and P. Krack. 2006. Pathological gambling in Parkinson’s disease improves on chronic subthalamic nucleus stimulation. Movement Disorders 21: 1941–1946.

    Article  Google Scholar 

  39. Smeding, H.M., A.E. Goudriaan, E.M. Foncke, P.R. Schuurman, J.D. Speelman, and B. Schmand. 2007. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. Journal of Neurology, Neurosurgery & Psychiatry 78: 517–519.

    Article  Google Scholar 

  40. Bannier, S., C. Montaurier, P.P. Derost, M. Ulla, J.J. Lemaire, Y. Boirie, B. Morio, and F. Durif. 2009. Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: Long term follow-up. Journal of Neurology Neurosurgery and Psychiatry 80: 484–488.

    Article  Google Scholar 

  41. Frank, M.J., J. Samanta, A.A. Moustafa, and S.J. Sherman. 2007. Hold your horses: Impulsivity, deep brain stimulation, and medication in Parkinsonism. Science 318: 1309–1312.

    Article  Google Scholar 

  42. Morgan, J.C., C.J. diDonato, S.S. Iyer, P.D. Jenkins, J.R. Smith, and K.D. Sethi. 2006. Self-stimulatory behavior associated with deep brain stimulation in Parkinson’s disease. Movement Disorders 21: 283–285.

    Article  Google Scholar 

  43. Olds, J., and P. Milner. 1954. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology 47: 419–427.

    Article  Google Scholar 

  44. Heinze, H.J., M. Heldmann, J. Voges, H. Hinrichs, J. Marco-Pallares, J.M. Hopf, U.J. Muller, I. Galazky, V. Sturm, B. Bogerts, and T.F. Munte. 2009. Counteracting incentive sensitization in severe alcohol dependence using deep brain stimulation of the nucleus accumbens: Clinical and basic science aspects. Frontiers in Human Neuroscience 3: 22.

    Article  Google Scholar 

  45. Kuhn, J., R. Bauer, S. Pohl, D. Lenartz, W. Huff, E.H. Kim, J. Klosterkoetter, and V. Sturm. 2009. Observations on unaided smoking cessation after deep brain stimulation of the nucleus accumbens. European Addiction Research 15: 196–201.

    Article  Google Scholar 

  46. Kuhn, J., D. Lenartz, W. Huff, S. Lee, A. Koulousakis, J. Klosterkoetter, and V. Sturm. 2007. Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: Valuable therapeutic implications? Journal of Neurology, Neurosurgery and Psychiatry 78: 1152–1153.

    Article  Google Scholar 

  47. Xu, J. 2007. Therapeutic effect of deep brain stimulation of the nucleus accumbens on refractory drug addiction: A case report. Neuromodulation: Technology at the Neural Interface, 8th World Congress of the International Neuromodulation Society; 2007 December 9–12, 2007; Acapulco, Mexico.

  48. Müller, U.J., V. Sturm, J. Voges, H.J. Heinze, I. Galazky, M. Heldmann, H. Scheich, and B. Bogerts. 2009. Successful treatment of chronic resistant alcoholism by beep brain stimulation of nucleus accumbens: First experience with three cases. Pharmacopsychiatry 42: 288–291.

    Article  Google Scholar 

  49. Bell, E., and E. Racine. 2007. Ethics in deep brain stimulation for alcohol dependence. Journal of Neurology, Neurosurgery and Psychiatry 78: 1152–1153.

    Article  Google Scholar 

  50. Strang, J., N. Metrebian, N. Lintzeris, L. Potts, T. Carnwath, S. Mayet, H. Williams, D. Zador, R. Evers, T. Groshkova, V. Charles, A. Martin, and L. Forzisi. 2010. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): A randomised trial. Lancet 375: 1885–1895.

    Article  Google Scholar 

  51. Valenstein, E.S. 1986. Great and desperate cures: The rise and decline of psychosurgery and other radical treatments for mental illness. New York: Basic Books.

    Google Scholar 

  52. Balasubramaniam, V., T.S. Kanaka, and P.B. Ramanujam. 1973. Stereotaxic cingulumotomy for drug addiction. Neurology India 21: 63–66.

    Google Scholar 

  53. Foltz, E.L., and L.E. White Jr. 1962. Pain “relief” by frontal cingulumotomy. Journal of Neurosurgery 19: 89–100.

    Article  Google Scholar 

  54. Kanaka, T.S., and V. Balasubramaniam. 1978. Stereotactic cingulumotomy for drug addiction. Applied Neurophysiology 41: 86–92.

    Google Scholar 

  55. Sharma, T. 1974. Abolition of opiate hunger in humans following bilateral anterior cingulotomy. Texas Medicine 70: 49–52.

    Google Scholar 

  56. Dieckmann, G., and H. Schneider. 1978. Influence of stereotactic hypothalamotomy on alcohol and drug addiction. Applied Neurophysiology 41: 93–98.

    Google Scholar 

  57. Muller, D., F. Roeder, and H. Orthner. 1973. Further results of stereotaxis in the human hypothalamus in sexual deviations. First use of this operation in addiction to drugs. Neurochirurgia 16: 113–126.

    Google Scholar 

  58. Knight, G. 1969. Chronic depression and drug addiction treated by stereotactic surgery. Nursing Times 65: 583–586.

    Google Scholar 

  59. Walsh, N.P. 2002. Russia bans brain surgery on drug addicts. The Guardian. 9 August: http://education.guardian.co.uk/higher/medicalscience/story/0,,771816,00.html. Accessed 11 February 2007.

  60. Xinhua News Agency. 2005. Brain surgery not resuming for curing drug addicts: Health ministry. Xinhua News Agency.

  61. Orellana, C. 2002. Controversy over brain surgery for heroin addiction in Russia. Lancet Neurology 1: 333.

    Article  Google Scholar 

  62. Goff, P. 2005. ‘I was conscious as they pushed the needle deep into my brain’. Telegraph. 19 November: http://www.telegraph.co.uk/news/main.jhtml?xml=/news/2005/11/20/wbrain20.xml. Accessed 6 July 2007.

  63. Medvedev, S.V., A.D. Anichkov, and I. Poltakov Iu. 2003. Physiological mechanisms of the effectiveness of bilateral stereotactic cingulotomy in treatment of strong psychological dependence in drug addiction. Fiziologiia Cheloveka 29: 117–123.

    Google Scholar 

  64. Nutt, D., and A. Lingford-Hughes. 2008. Addiction: The clinical interface. British Journal of Pharmacology 154: 397–405.

    Article  Google Scholar 

  65. Lingford-Hughes, A., S. Welch, and D. Nutt. 2004. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 18: 293–335.

    Article  Google Scholar 

  66. McNeely, H.E., H.S. Mayberg, A.M. Lozano, and S.H. Kennedy. 2008. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: Preliminary results over 12 months. Journal of Nervous and Mental Disease 196: 405–410.

    Article  Google Scholar 

  67. Smeding, H.M., J.D. Speelman, M. Koning-Haanstra, P.R. Schuurman, P. Nijssen, T. van Laar, and B. Schmand. 2006. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study. Neurology 66: 1830–1836.

    Article  Google Scholar 

  68. Kenney, C., R. Simpson, C. Hunter, W. Ondo, M. Almaguer, A. Davidson, and J. Jankovic. 2007. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. Journal of Neurosurgery 106: 621–625.

    Article  Google Scholar 

  69. Agid, Y., M. Schupbach, M. Gargiulo, L. Mallet, J.L. Houeto, C. Behar, D. Maltete, V. Mesnage, and M.L. Welter. 2006. Neurosurgery in Parkinson’s disease: The doctor is happy, the patient less so? Journal of Neural Transmission Supplementum 70: 409–414.

    Article  Google Scholar 

  70. Schupbach, M., M. Gargiulo, M.L. Welter, L. Mallet, C. Behar, J.L. Houeto, D. Maltete, V. Mesnage, and Y. Agid. 2006. Neurosurgery in Parkinson disease: A distressed mind in a repaired body? Neurology 66: 1811–1816.

    Article  Google Scholar 

  71. Abelson, J.L., G.C. Curtis, O. Sagher, R.C. Albucher, M. Harrigan, S.F. Taylor, B. Martis, and B. Giordani. 2005. Deep brain stimulation for refractory obsessive–compulsive disorder. Biological Psychiatry 57: 510–516.

    Article  Google Scholar 

  72. Gisquet, E. 2008. Cerebral implants and Parkinson’s disease: A unique form of biographical disruption? Social Science and Medicine 67: 1847–1851.

    Article  Google Scholar 

  73. Bell, E., B. Maxwell, A. Sadikot, M. McAndrews, and E. Racine. 2010. Healthcare providers perspectives and approaches. Journal of Clinical Ethics 21: 113–125.

    Google Scholar 

  74. Racine, E., S. Waldman, N. Palmour, D. Risse, and J. Illes. 2007. “Currents of hope”: Neurostimulation techniques in U.S. and U.K. print media. Cambridge Quarterly of Healthcare Ethics 16: 312–316.

    Google Scholar 

  75. Badenoch, J. 2002. A death following ultra-rapid opiate detoxification: The General Medical Council adjudicates on a commercialized detoxification. Addiction 97: 475–477.

    Article  Google Scholar 

  76. Hamilton, R.J., R.E. Olmedo, S. Shah, O.L. Hung, M.A. Howland, J. Perrone, L.S. Nelson, N.L. Lewin, and R.S. Hoffman. 2002. Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets. Academic Emergency Medicine 9: 63–68.

    Article  Google Scholar 

  77. Bell, E., G. Mathieu, and E. Racine. 2009. Preparing the ethical future of deep brain stimulation. Surgical Neurology 72: 577–586.

    Article  Google Scholar 

  78. Rabins, P., B.S. Appleby, J. Brandt, M.R. DeLong, L.B. Dunn, L. Gabriels, B.D. Greenberg, S.N. Haber, P.E. Holtzheimer, Z. Mari, H.S. Mayberg, E. McCann, S.P. Mink, S. Rasmussen, T.E. Schlaepfer, D.E. Vawter, J.L. Vitek, J. Walkup, and D.J.H. Mathews. 2009. Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Archives of General Psychiatry 66: 931–937.

    Article  Google Scholar 

  79. Schlaepfer, T.E., and J.J. Fins. 2010. Deep brain stimulation and the neuroethics of responsible publishing: When one is not enough. JAMA 303: 775–776.

    Article  Google Scholar 

  80. Mattick, R.P., C. Breen, J. Kimber, and M. Davoli. 2009. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 3: CD002209.

    Google Scholar 

  81. Mattick, R.P., J. Kimber, C. Breen, and M. Davoli. 2008. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2: CD002207.

    Google Scholar 

  82. Carter, A., and W. Hall. 2008. Informed consent to opioid agonist maintenance treatment: Recommended ethical guidelines. International Journal of Drug Policy 19: 79–89.

    Article  Google Scholar 

  83. Lintzeris, N. 2009. Prescription of heroin for the management of heroin dependence: Current status. CNS Drugs 23: 463–476.

    Article  Google Scholar 

  84. Carter, A., and W. Hall. 2007. The ethical use of psychosocially assisted pharmacological treatment of opioid dependence. Geneva: World Health Organization.

    Google Scholar 

  85. Carter, A., and W. Hall. 2007. The social implications of neurobiological explanations of resistible compulsions. American Journal of Bioethics 7: 15–17.

    Google Scholar 

  86. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1977. Psychosurgery: Reports and recommendations. Washington, D.C.: US Government Printing Office.

    Google Scholar 

  87. Baltuch, G.H., and M.B. Stern. 2007. Deep brain stimulation for Parkinson’s disease. New York: Informa Healthcare.

    Google Scholar 

  88. Australian Bureau of Statistics. 2007. National survey of mental health and wellbeing: Summary of results. Canberra: Australian Bureau of Statistics.

    Google Scholar 

  89. Perozzo, P., M. Rizzone, B. Bergamasco, L. Castelli, M. Lanotte, A. Tavella, E. Torre, and L. Lopiano. 2001. Deep brain stimulation of subthalamic nucleus: Behavioural modifications and familiar relations. Neurological Sciences 22: 81–82.

    Article  Google Scholar 

  90. Okun, M., R. Rodriguez, K. Foote, A. Sudhyadhom, F. Bova, C. Jacobson, B. Bello, P. Zeilman, and H. Fernandez. 2008. A case-based review of troubleshooting deep brain stimulator issues in movement and neuropsychiatric disorders. Parkinsonism and Related Disorders 14: 532–538.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank Ms Danielle Herbert for her assistance in researching this paper and Ms Sarah Yeates for comments on an earlier draft. This manuscript was prepared with financial assistance from a National Health and Medical Research Council Australia Fellowship (Grant No. 3020774) awarded to Professor Wayne Hall.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adrian Carter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carter, A., Bell, E., Racine, E. et al. Ethical Issues Raised by Proposals to Treat Addiction Using Deep Brain Stimulation. Neuroethics 4, 129–142 (2011). https://doi.org/10.1007/s12152-010-9091-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12152-010-9091-3

Keywords

Navigation